BEHAVIORAL PHARMACOLOGICAL PROFILE OF CGS-9895 - A NOVEL ANXIOMODULATOR WITH SELECTIVE BENZODIAZEPINE AGONIST AND ANTAGONIST PROPERTIES

被引：29
|
作者：
BENNETT, DA
AMRICK, CL
WILSON, DE
BERNARD, PS
YOKOYAMA, N
LIEBMAN, JM
机构：
来源：
DRUG DEVELOPMENT RESEARCH | 1985年 / 6卷 / 04期
关键词：
D O I：
10.1002/ddr.430060404
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：313 / 325
页数：13
相关论文
共 50 条
  • [21] Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist
    McNamara, Alexander
    Pulido-Rios, Maria Teresa
    Sweazey, Shelley
    Obedencio, Glenmar P.
    Thibodeaux, Harold
    Renner, Travis
    Armstrong, Scott R.
    Steinfeld, Tod
    Hughes, Adam D.
    Wilson, Richard D.
    Jasper, Jeffrey R.
    Mammen, Mathai
    Hegde, Sharath S.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 605 (1-3) : 145 - 152
  • [22] Pharmacological profile of a novel and selective 5-HT6 receptor agonist: WAY-466
    Schechter, L. E.
    Smith, D. L.
    Li, P.
    Lin, Q.
    Rosenzweig-Lipson, S.
    Beyer, C. E.
    Robichaud, A.
    Bernotas, R.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 146 - 146
  • [23] PHARMACOLOGICAL AND HEMODYNAMIC PROFILE OF NEBIVOLOL, A CHEMICALLY NOVEL, POTENT, AND SELECTIVE BETA-1-ADRENERGIC ANTAGONIST
    VANDEWATER, A
    JANSSENS, W
    VANNEUTEN, J
    XHONNEUX, R
    DECREE, J
    VERHAEGEN, H
    RENEMAN, RS
    JANSSEN, PAJ
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 11 (05) : 552 - 563
  • [24] EARLY CLINICAL PHARMACOLOGICAL TRIALS WITH A NOVEL PARTIAL BENZODIAZEPINE AGONIST ANTAGONIST RO 17-1812 USING PHARMACO-EEG AND PSYCHOMETRY
    SALETU, B
    GRUNBERGER, J
    LINZMAYER, L
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1986, 8 (06): : 373 - 389
  • [25] A PHARMACOLOGICAL PROFILE OF THE NOVEL, PERIPHERALLY-SELECTIVE KAPPA-OPIOID RECEPTOR AGONIST, EMD-61753
    BARBER, A
    BARTOSZYK, GD
    BENDER, HM
    GOTTSCHLICH, R
    GREINER, HE
    HARTING, J
    MAULER, F
    MINCK, KO
    MURRAY, RD
    SIMON, M
    SEYFRIED, CA
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (04) : 1317 - 1327
  • [26] Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist
    Esbenshade, TA
    Fox, GB
    Krueger, KM
    Baranowski, JL
    Miller, TR
    Kang, CH
    Denny, LI
    Witte, DG
    Yao, BB
    Pan, JB
    Faghih, R
    Bennani, YL
    Williams, M
    Hancock, AA
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (05) : 933 - 945
  • [27] PHARMACOLOGICAL PROFILE OF UK-74,505, A NOVEL AND SELECTIVE PAF ANTAGONIST WITH POTENT AND PROLONGED ORAL ACTIVITY
    PARRY, MJ
    ALABASTER, VA
    CHEESEMAN, HE
    COOPER, K
    DESOUZA, RN
    KEIR, RF
    JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1994, 10 (03): : 251 - 268
  • [28] Pharmacological profile of VP-343, a novel selective vasopressin V2 receptor antagonist, in rats
    Naito, A
    Ohtake, Y
    Hasegawa, H
    Fukaya, Y
    Kurasawa, T
    Naito, K
    Matsukawa, H
    Oguma, T
    Ezure, Y
    Tsuriya, Y
    Tanaka, H
    Koike, K
    Shigenobu, K
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2000, 23 (02) : 182 - 189
  • [29] SL-84.0418 - A NOVEL, POTENT AND SELECTIVE ALPHA-2 ADRENOCEPTOR ANTAGONIST - INVITRO PHARMACOLOGICAL PROFILE
    ANGEL, I
    SCHOEMAKER, H
    ARBILLA, S
    GALZIN, AM
    BERRY, C
    NIDDAM, R
    PIMOULE, C
    SEVRIN, M
    WICK, A
    LANGER, SZ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 263 (03): : 1327 - 1333
  • [30] BEHAVIORAL PHARMACOLOGICAL PROPERTIES OF THE NOVEL ANTIDEPRESSANT PAROXETINE, A SELECTIVE 5-HT UPTAKE INHIBITOR
    YAMAMOTO, T
    SHIBATA, S
    SHIMAZOE, T
    IWASAKI, K
    OHNO, M
    MINAMOTO, Y
    FURUYA, Y
    MIYAMOTO, K
    WATANABE, S
    UEKI, S
    MANNO, K
    SUGIHARA, K
    FOLIA PHARMACOLOGICA JAPONICA, 1989, 94 (03) : 189 - 206
12345